ADD Will Offer European Drug Delivery Partnerships Via Novartis Funding
Executive Summary
Advanced Drug Delivery Technologies is using Novartis Venture Fund financing to seek European partnering opportunities with pharmaceutical clients who traditionally have had to go to the U.S. in search of collaborators.
You may also be interested in...
Biotech Exit Strategy Of Choice Is Acquisition, Not IPO, Investor Says
Venture capital firms are increasingly shaping biotech companies to look like acquisition prospects from the outset, rather than candidates for initial public offerings, according to one investor's analysis
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011